93 related articles for article (PubMed ID: 30719275)
1. Polymorphisms of
Chang KH; Chen CM; Chen YC; Fung HC; Wu YR
Parkinsons Dis; 2019; 2019():3489638. PubMed ID: 30719275
[TBL] [Abstract][Full Text] [Related]
2. Association of three candidate genetic variants in ACMSD/TMEM163, GPNMB and BCKDK /STX1B with sporadic Parkinson's disease in Han Chinese.
Wang L; Li NN; Lu ZJ; Li JY; Peng JX; Duan LR; Peng R
Neurosci Lett; 2019 Jun; 703():45-48. PubMed ID: 30880162
[TBL] [Abstract][Full Text] [Related]
3. Association study of MCCC1/LAMP3 and DGKQ variants with Parkinson's disease in patients of Malay ancestry.
Lim JL; Ng EY; Lim SY; Tan AH; Abdul-Aziz Z; Ibrahim KA; Gopalai AA; Tay YW; Vijayanathan Y; Toh TS; Lim SK; Bee PC; Puvanarajah SD; Viswanathan S; Looi I; Lim TT; Eow GB; Cheah WK; Tan EK; Ahmad-Annuar A
Neurol Sci; 2021 Oct; 42(10):4203-4207. PubMed ID: 33559030
[TBL] [Abstract][Full Text] [Related]
4. A replication study of GWAS-genetic risk variants associated with Parkinson's disease in a Spanish population.
Tejera-Parrado C; Jesús S; Periñán MT; Buiza-Rueda D; Oliva-Ariza G; Adarmes-Gómez AD; Macías-García D; Gómez-Garre P; Mir P
Neurosci Lett; 2019 Nov; 712():134425. PubMed ID: 31430546
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic variants within HLA-DR region with Parkinson's disease in Taiwan.
Chang KH; Wu YR; Chen YC; Fung HC; Chen CM
Neurobiol Aging; 2020 Mar; 87():140.e13-140.e18. PubMed ID: 31818508
[TBL] [Abstract][Full Text] [Related]
6. Association of GCH1 and MIR4697, but not SIPA1L2 and VPS13C polymorphisms, with Parkinson's disease in Taiwan.
Chen CM; Chen YC; Chiang MC; Fung HC; Chang KH; Lee-Chen GJ; Wu YR
Neurobiol Aging; 2016 Mar; 39():221.e1-5. PubMed ID: 26804608
[TBL] [Abstract][Full Text] [Related]
7. Integrating multi-omics data to reveal the effect of genetic variant rs6430538 on Alzheimer's disease risk.
Qiu S; Sun M; Xu Y; Hu Y
Front Neurosci; 2024; 18():1277187. PubMed ID: 38562299
[TBL] [Abstract][Full Text] [Related]
8. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
Davis AA; Andruska KM; Benitez BA; Racette BA; Perlmutter JS; Cruchaga C
Neurobiol Aging; 2016 Jan; 37():209.e1-209.e7. PubMed ID: 26601739
[TBL] [Abstract][Full Text] [Related]
9. Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease.
Pihlstrøm L; Axelsson G; Bjørnarå KA; Dizdar N; Fardell C; Forsgren L; Holmberg B; Larsen JP; Linder J; Nissbrandt H; Tysnes OB; Ohman E; Dietrichs E; Toft M
Neurobiol Aging; 2013 Jun; 34(6):1708.e7-13. PubMed ID: 23153929
[TBL] [Abstract][Full Text] [Related]
10. Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease?
Thirtamara-Rajamani K; Li P; Escobar Galvis ML; Labrie V; Brundin P; Brundin L
J Parkinsons Dis; 2017; 7(4):577-587. PubMed ID: 29103054
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of
Liu TW; Wu YR; Chen YC; Fung HC; Chen CM
Brain Sci; 2021 Jun; 11(6):. PubMed ID: 34207646
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease susceptibility variants and severity of Lewy body pathology.
Heckman MG; Kasanuki K; Diehl NN; Koga S; Soto A; Murray ME; Dickson DW; Ross OA
Parkinsonism Relat Disord; 2017 Nov; 44():79-84. PubMed ID: 28917824
[TBL] [Abstract][Full Text] [Related]
13. Association of AXIN1 With Parkinson's Disease in a Taiwanese Population.
Fang HS; Chao CY; Wang CC; Fan WL; Huang PJ; Fung HC; Wu YR
J Mov Disord; 2022 Jan; 15(1):33-37. PubMed ID: 34781631
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide assessment of Parkinson's disease in a Southern Spanish population.
Bandrés-Ciga S; Price TR; Barrero FJ; Escamilla-Sevilla F; Pelegrina J; Arepalli S; Hernández D; Gutiérrez B; Cervilla J; Rivera M; Rivera A; Ding JH; Vives F; Nalls M; Singleton A; Durán R
Neurobiol Aging; 2016 Sep; 45():213.e3-213.e9. PubMed ID: 27393345
[TBL] [Abstract][Full Text] [Related]
15. Association between CSF1 and CSF1R Polymorphisms and Parkinson's Disease in Taiwan.
Chang KH; Wu YR; Chen YC; Wu HC; Chen CM
J Clin Med; 2019 Sep; 8(10):. PubMed ID: 31554150
[TBL] [Abstract][Full Text] [Related]
16. Dataset reporting BCKDK interference in a BCAA-catabolism restricted environment.
Bravo-Alonso I; Oyarzabal A; Sánchez-Aragó M; Rejas MT; Merinero B; García-Cazorla A; Artuch R; Ugarte M; Rodríguez-Pombo P
Data Brief; 2016 Jun; 7():755-9. PubMed ID: 27054191
[TBL] [Abstract][Full Text] [Related]
17. A Novel p.Glu298Lys Mutation in the ACMSD Gene in Sporadic Parkinson's Disease.
Vilas D; Fernández-Santiago R; Sanchez E; Azcona LJ; Santos-Montes M; Casquero P; Argandoña L; Tolosa E; Paisán-Ruiz C
J Parkinsons Dis; 2017; 7(3):459-463. PubMed ID: 28671144
[TBL] [Abstract][Full Text] [Related]
18. Data on the proliferation and differentiation of C2C12 myoblast treated with branched-chain ketoacid dehydrogenase kinase inhibitor.
Sato Y; Tate H; Yoshizawa F; Sato Y
Data Brief; 2020 Aug; 31():105766. PubMed ID: 32529013
[TBL] [Abstract][Full Text] [Related]
19. BST1 rs11724635 interacts with environmental factors to increase the risk of Parkinson's disease in a Taiwanese population.
Chen ML; Lin CH; Lee MJ; Wu RM
Parkinsonism Relat Disord; 2014 Mar; 20(3):280-3. PubMed ID: 24342025
[TBL] [Abstract][Full Text] [Related]
20. MCCC1/LAMP3 reduces risk of sporadic Parkinson's disease in Han Chinese.
Li NN; Tan EK; Chang XL; Mao XY; Zhao DM; Zhang JH; Liao Q; Peng R
Acta Neurol Scand; 2013 Aug; 128(2):136-9. PubMed ID: 23496138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
